{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:46:50Z","timestamp":1792446410614,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T00:00:00Z","timestamp":1496016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Struct Mol Biol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/nsmb.3414","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T14:58:15Z","timestamp":1496069895000},"page":"578-587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5912-074X","authenticated-orcid":false,"given":"Koji","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Klejnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K","family":"Hock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J","family":"Sibbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H","family":"Vousden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny T","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,29]]},"reference":[{"key":"BFnsmb3414_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/378206a0","volume":"378","author":"SN Jones","year":"1995","unstructured":"Jones, S.N., Roe, A.E., Donehower, L.A. & Bradley, A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206\u2013208 (1995).","journal-title":"Nature"},{"key":"BFnsmb3414_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/378203a0","volume":"378","author":"R Montes de Oca Luna","year":"1995","unstructured":"Montes de Oca Luna, R., Wagner, D.S. & Lozano, G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203\u2013206 (1995).","journal-title":"Nature"},{"key":"BFnsmb3414_CR3","first-page":"3221","volume":"62","author":"RA Finch","year":"2002","unstructured":"Finch, R.A. et al. mdmx is a negative regulator of p53 activity in vivo. Cancer Res. 62, 3221\u20133225 (2002).","journal-title":"Cancer Res."},{"key":"BFnsmb3414_CR4","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1128\/MCB.22.15.5527-5538.2002","volume":"22","author":"D Migliorini","year":"2002","unstructured":"Migliorini, D. et al. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol. Cell. Biol. 22, 5527\u20135538 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"BFnsmb3414_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ng714","volume":"29","author":"J Parant","year":"2001","unstructured":"Parant, J. et al. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat. Genet. 29, 92\u201395 (2001).","journal-title":"Nat. Genet."},{"key":"BFnsmb3414_CR6","doi-asserted-by":"publisher","first-page":"12001","DOI":"10.1073\/pnas.1102309108","volume":"108","author":"L Huang","year":"2011","unstructured":"Huang, L. et al. The p53 inhibitors MDM2\/MDMX complex is required for control of p53 activity in vivo. Proc. Natl. Acad. Sci. USA 108, 12001\u201312006 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3414_CR7","doi-asserted-by":"publisher","first-page":"11995","DOI":"10.1073\/pnas.1102241108","volume":"108","author":"V Pant","year":"2011","unstructured":"Pant, V., Xiong, S., Iwakuma, T., Quint\u00e1s-Cardama, A. & Lozano, G. Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability. Proc. Natl. Acad. Sci. USA 108, 11995\u201312000 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3414_CR8","first-page":"1001","volume":"1","author":"UM Moll","year":"2003","unstructured":"Moll, U.M. & Petrenko, O. The MDM2-p53 interaction. Mol. Cancer Res. 1, 1001\u20131008 (2003).","journal-title":"Mol. Cancer Res."},{"key":"BFnsmb3414_CR9","doi-asserted-by":"publisher","first-page":"17814","DOI":"10.1073\/pnas.1317398110","volume":"110","author":"M Bista","year":"2013","unstructured":"Bista, M., Petrovich, M. & Fersht, A.R. MDMX contains an autoinhibitory sequence element. Proc. Natl. Acad. Sci. USA 110, 17814\u201317819 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3414_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1128\/MCB.20.3.1001-1007.2000","volume":"20","author":"MW Jackson","year":"2000","unstructured":"Jackson, M.W. & Berberich, S.J. MdmX protects p53 from Mdm2-mediated degradation. Mol. Cell. Biol. 20, 1001\u20131007 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BFnsmb3414_CR11","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/embo-reports\/kve227","volume":"2","author":"R Stad","year":"2001","unstructured":"Stad, R. et al. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2, 1029\u20131034 (2001).","journal-title":"EMBO Rep."},{"key":"BFnsmb3414_CR12","doi-asserted-by":"publisher","first-page":"49668","DOI":"10.1074\/jbc.M208593200","volume":"277","author":"JC Badciong","year":"2002","unstructured":"Badciong, J.C. & Haas, A.L. MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination. J. Biol. Chem. 277, 49668\u201349675 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnsmb3414_CR13","doi-asserted-by":"publisher","first-page":"33065","DOI":"10.1074\/jbc.M110.115113","volume":"285","author":"S Iyappan","year":"2010","unstructured":"Iyappan, S. et al. Turning the RING domain protein MdmX into an active ubiquitin-protein ligase. J. Biol. Chem. 285, 33065\u201333072 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnsmb3414_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.molcel.2004.10.016","volume":"16","author":"N Minsky","year":"2004","unstructured":"Minsky, N. & Oren, M. The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol. Cell 16, 631\u2013639 (2004).","journal-title":"Mol. Cell"},{"key":"BFnsmb3414_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1947601912455199","volume":"3","author":"D Shi","year":"2012","unstructured":"Shi, D. & Gu, W. Dual roles of MDM2 in the regulation of p53: ubiquitination dependent and ubiquitination independent mechanisms of MDM2 repression of p53 activity. Genes Cancer 3, 240\u2013248 (2012).","journal-title":"Genes Cancer"},{"key":"BFnsmb3414_CR16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","volume":"69","author":"J Momand","year":"1992","unstructured":"Momand, J., Zambetti, G.P., Olson, D.C., George, D. & Levine, A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237\u20131245 (1992).","journal-title":"Cell"},{"key":"BFnsmb3414_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/362857a0","volume":"362","author":"JD Oliner","year":"1993","unstructured":"Oliner, J.D. et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857\u2013860 (1993).","journal-title":"Nature"},{"key":"BFnsmb3414_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ccr.2007.09.007","volume":"12","author":"K Itahana","year":"2007","unstructured":"Itahana, K. et al. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 12, 355\u2013366 (2007).","journal-title":"Cancer Cell"},{"key":"BFnsmb3414_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/sj.emboj.7601469","volume":"26","author":"S Uldrijan","year":"2007","unstructured":"Uldrijan, S., Pannekoek, W.J. & Vousden, K.H. An essential function of the extreme C-terminus of MDM2 can be provided by MDMX. EMBO J. 26, 102\u2013112 (2007).","journal-title":"EMBO J."},{"key":"BFnsmb3414_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/sj.emboj.7601465","volume":"26","author":"MV Poyurovsky","year":"2007","unstructured":"Poyurovsky, M.V. et al. The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity. EMBO J. 26, 90\u2013101 (2007).","journal-title":"EMBO J."},{"key":"BFnsmb3414_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ccr.2014.06.006","volume":"26","author":"LA Tollini","year":"2014","unstructured":"Tollini, L.A., Jin, A., Park, J. & Zhang, Y. Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage. Cancer Cell 26, 235\u2013247 (2014).","journal-title":"Cancer Cell"},{"key":"BFnsmb3414_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrd4236","volume":"13","author":"KH Khoo","year":"2014","unstructured":"Khoo, K.H., Verma, C.S. & Lane, D.P. Drugging the p53 pathway: understanding the route to clinical efficacy. Nat. Rev. Drug Discov. 13, 217\u2013236 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnsmb3414_CR23","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1073\/pnas.0708917105","volume":"105","author":"S Shangary","year":"2008","unstructured":"Shangary, S. et al. Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proc. Natl. Acad. Sci. USA 105, 3933\u20133938 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3414_CR24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.1092472","volume":"303","author":"LT Vassilev","year":"2004","unstructured":"Vassilev, L.T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844\u2013848 (2004).","journal-title":"Science"},{"key":"BFnsmb3414_CR25","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1021\/jm400487c","volume":"56","author":"Q Ding","year":"2013","unstructured":"Ding, Q. et al. Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development. J. Med. Chem. 56, 5979\u20135983 (2013).","journal-title":"J. Med. Chem."},{"key":"BFnsmb3414_CR26","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1158\/1078-0432.CCR-15-0481","volume":"22","author":"M Andreeff","year":"2016","unstructured":"Andreeff, M. et al. Results of the phase I trial of RG7112, a small-molecule MDM2 antagonist in leukemia. Clin. Cancer Res. 22, 868\u2013876 (2016).","journal-title":"Clin. Cancer Res."},{"key":"BFnsmb3414_CR27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1470-2045(12)70474-6","volume":"13","author":"I Ray-Coquard","year":"2012","unstructured":"Ray-Coquard, I. et al. Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. Lancet Oncol. 13, 1133\u20131140 (2012).","journal-title":"Lancet Oncol."},{"key":"BFnsmb3414_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/sj.cdd.4402309","volume":"15","author":"K Linke","year":"2008","unstructured":"Linke, K. et al. Structure of the MDM2\/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ. 15, 841\u2013848 (2008).","journal-title":"Cell Death Differ."},{"key":"BFnsmb3414_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jmb.2006.08.027","volume":"363","author":"M Kostic","year":"2006","unstructured":"Kostic, M., Matt, T., Martinez-Yamout, M.A., Dyson, H.J. & Wright, P.E. Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53. J. Mol. Biol. 363, 433\u2013450 (2006).","journal-title":"J. Mol. Biol."},{"key":"BFnsmb3414_CR30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nsmb.2621","volume":"20","author":"H Dou","year":"2013","unstructured":"Dou, H., Buetow, L., Sibbet, G.J., Cameron, K. & Huang, D.T. Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nat. Struct. Mol. Biol. 20, 982\u2013986 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnsmb3414_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature11376","volume":"489","author":"A Plechanovov\u00e1","year":"2012","unstructured":"Plechanovov\u00e1, A., Jaffray, E.G., Tatham, M.H., Naismith, J.H. & Hay, R.T. Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature 489, 115\u2013120 (2012).","journal-title":"Nature"},{"key":"BFnsmb3414_CR32","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nsmb.2379","volume":"19","author":"H Dou","year":"2012","unstructured":"Dou, H., Buetow, L., Sibbet, G.J., Cameron, K. & Huang, D.T. BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer. Nat. Struct. Mol. Biol. 19, 876\u2013883 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnsmb3414_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nsmb.3052","volume":"22","author":"E Branigan","year":"2015","unstructured":"Branigan, E., Plechanovov\u00e1, A., Jaffray, E.G., Naismith, J.H. & Hay, R.T. Structural basis for the RING-catalyzed synthesis of K63-linked ubiquitin chains. Nat. Struct. Mol. Biol. 22, 597\u2013602 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnsmb3414_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molcel.2015.02.017","volume":"58","author":"L Buetow","year":"2015","unstructured":"Buetow, L. et al. Activation of a primed RING E3-E2-ubiquitin complex by non-covalent ubiquitin. Mol. Cell 58, 297\u2013310 (2015).","journal-title":"Mol. Cell"},{"key":"BFnsmb3414_CR35","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.15252\/embj.201593741","volume":"35","author":"MG Koliopoulos","year":"2016","unstructured":"Koliopoulos, M.G., Esposito, D., Christodoulou, E., Taylor, I.A. & Rittinger, K. Functional role of TRIM E3 ligase oligomerization and regulation of catalytic activity. EMBO J. 35, 1204\u20131218 (2016).","journal-title":"EMBO J."},{"key":"BFnsmb3414_CR36","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.celrep.2016.06.070","volume":"16","author":"JG Sanchez","year":"2016","unstructured":"Sanchez, J.G. et al. Mechanism of TRIM25 catalytic activation in the antiviral RIG-I pathway. Cell Rep. 16, 1315\u20131325 (2016).","journal-title":"Cell Rep."},{"key":"BFnsmb3414_CR37","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cell.2014.04.037","volume":"157","author":"DC Scott","year":"2014","unstructured":"Scott, D.C. et al. Structure of a RING E3 trapped in action reveals ligation mechanism for the ubiquitin-like protein NEDD8. Cell 157, 1671\u20131684 (2014).","journal-title":"Cell"},{"key":"BFnsmb3414_CR38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.molcel.2012.07.001","volume":"47","author":"JN Pruneda","year":"2012","unstructured":"Pruneda, J.N. et al. Structure of an E3:E2\u223cUb complex reveals an allosteric mechanism shared among RING\/U-box ligases. Mol. Cell 47, 933\u2013942 (2012).","journal-title":"Mol. Cell"},{"key":"BFnsmb3414_CR39","doi-asserted-by":"publisher","first-page":"953","DOI":"10.4161\/cc.11.5.19445","volume":"11","author":"P Dolezelova","year":"2012","unstructured":"Dolezelova, P., Cetkovska, K., Vousden, K.H. & Uldrijan, S. Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2\/MdmX heterodimers. Cell Cycle 11, 953\u2013962 (2012).","journal-title":"Cell Cycle"},{"key":"BFnsmb3414_CR40","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/nsmb.2108","volume":"18","author":"A Plechanovov\u00e1","year":"2011","unstructured":"Plechanovov\u00e1, A. et al. Mechanism of ubiquitylation by dimeric RING ligase RNF4. Nat. Struct. Mol. Biol. 18, 1052\u20131059 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnsmb3414_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","volume":"420","author":"R Honda","year":"1997","unstructured":"Honda, R., Tanaka, H. & Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25\u201327 (1997).","journal-title":"FEBS Lett."},{"key":"BFnsmb3414_CR42","first-page":"87","volume":"10","author":"MHG Kubbutat","year":"1999","unstructured":"Kubbutat, M.H.G., Ludwig, R.L., Levine, A.J. & Vousden, K.H. Analysis of the degradation function of Mdm2. Cell Growth Differ. 10, 87\u201392 (1999).","journal-title":"Cell Growth Differ."},{"key":"BFnsmb3414_CR43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/35023507","volume":"2","author":"RK Geyer","year":"2000","unstructured":"Geyer, R.K., Yu, Z.K. & Maki, C.G. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2, 569\u2013573 (2000).","journal-title":"Nat. Cell Biol."},{"key":"BFnsmb3414_CR44","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0092-8674(00)00057-X","volume":"102","author":"N Zheng","year":"2000","unstructured":"Zheng, N., Wang, P., Jeffrey, P.D. & Pavletich, N.P. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533\u2013539 (2000).","journal-title":"Cell"},{"key":"BFnsmb3414_CR45","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1073\/pnas.0836054100","volume":"100","author":"PS Brzovic","year":"2003","unstructured":"Brzovic, P.S. et al. Binding and recognition in the assembly of an active BRCA1\/BARD1 ubiquitin-ligase complex. Proc. Natl. Acad. Sci. USA 100, 5646\u20135651 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3414_CR46","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nsmb1295","volume":"14","author":"DE Christensen","year":"2007","unstructured":"Christensen, D.E., Brzovic, P.S. & Klevit, R.E. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat. Struct. Mol. Biol. 14, 941\u2013948 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnsmb3414_CR47","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1128\/MCB.23.14.4929-4938.2003","volume":"23","author":"E Meulmeester","year":"2003","unstructured":"Meulmeester, E. et al. Critical role for a central part of Mdm2 in the ubiquitylation of p53. Mol. Cell. Biol. 23, 4929\u20134938 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnsmb3414_CR48","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/sj.onc.1204241","volume":"20","author":"M Argentini","year":"2001","unstructured":"Argentini, M., Barboule, N. & Wasylyk, B. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability. Oncogene 20, 1267\u20131275 (2001).","journal-title":"Oncogene"},{"key":"BFnsmb3414_CR49","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1128\/MCB.23.14.4939-4947.2003","volume":"23","author":"H Kawai","year":"2003","unstructured":"Kawai, H., Wiederschain, D. & Yuan, Z.M. Critical contribution of the MDM2 acidic domain to p53 ubiquitination. Mol. Cell. Biol. 23, 4939\u20134947 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnsmb3414_CR50","doi-asserted-by":"publisher","first-page":"44475","DOI":"10.1074\/jbc.M403722200","volume":"279","author":"MS Dai","year":"2004","unstructured":"Dai, M.S. & Lu, H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 279, 44475\u201344482 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnsmb3414_CR51","doi-asserted-by":"publisher","first-page":"7654","DOI":"10.1128\/MCB.24.17.7654-7668.2004","volume":"24","author":"MS Dai","year":"2004","unstructured":"Dai, M.S. et al. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol. Cell. Biol. 24, 7654\u20137668 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"BFnsmb3414_CR52","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.4161\/cc.8.17.9503","volume":"8","author":"ML Choong","year":"2009","unstructured":"Choong, M.L., Yang, H., Lee, M.A. & Lane, D.P. Specific activation of the p53 pathway by low dose actinomycin D: a new route to p53 based cyclotherapy. Cell Cycle 8, 2810\u20132818 (2009).","journal-title":"Cell Cycle"},{"key":"BFnsmb3414_CR53","doi-asserted-by":"crossref","first-page":"693","DOI":"10.18632\/oncotarget.1328","volume":"5","author":"CS Chen","year":"2014","unstructured":"Chen, C.S. et al. AKT mediates actinomycin D-induced p53 expression. Oncotarget 5, 693\u2013703 (2014).","journal-title":"Oncotarget"},{"key":"BFnsmb3414_CR54","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1128\/MCB.23.15.5113-5121.2003","volume":"23","author":"Y Pan","year":"2003","unstructured":"Pan, Y. & Chen, J. MDM2 promotes ubiquitination and degradation of MDMX. Mol. Cell. Biol. 23, 5113\u20135121 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnsmb3414_CR55","doi-asserted-by":"publisher","first-page":"45946","DOI":"10.1074\/jbc.M308295200","volume":"278","author":"H Kawai","year":"2003","unstructured":"Kawai, H. et al. DNA damage-induced MDMX degradation is mediated by MDM2. J. Biol. Chem. 278, 45946\u201345953 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnsmb3414_CR56","doi-asserted-by":"publisher","first-page":"12009","DOI":"10.1073\/pnas.2030930100","volume":"100","author":"LK Linares","year":"2003","unstructured":"Linares, L.K., Hengstermann, A., Ciechanover, A., M\u00fcller, S. & Scheffner, M. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc. Natl. Acad. Sci. USA 100, 12009\u201312014 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3414_CR57","doi-asserted-by":"crossref","first-page":"28039","DOI":"10.1074\/jbc.M003496200","volume":"275","author":"R Stad","year":"2000","unstructured":"Stad, R. et al. Hdmx stabilizes Mdm2 and p53. J. Biol. Chem. 275, 28039\u201328044 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnsmb3414_CR58","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrm.2016.91","volume":"17","author":"L Buetow","year":"2016","unstructured":"Buetow, L. & Huang, D.T. Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 17, 626\u2013642 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnsmb3414_CR59","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1128\/MCB.05553-11","volume":"31","author":"Q Cheng","year":"2011","unstructured":"Cheng, Q. et al. Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage. Mol. Cell. Biol. 31, 4951\u20134963 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"BFnsmb3414_CR60","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1128\/MCB.00246-14","volume":"34","author":"Q Cheng","year":"2014","unstructured":"Cheng, Q., Song, T., Chen, L. & Chen, J. Autoactivation of the MDM2 E3 ligase by intramolecular interaction. Mol. Cell. Biol. 34, 2800\u20132810 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"BFnsmb3414_CR61","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/carcin\/bgs092","volume":"33","author":"P Roxburgh","year":"2012","unstructured":"Roxburgh, P. et al. Small molecules that bind the Mdm2 RING stabilize and activate p53. Carcinogenesis 33, 791\u2013798 (2012).","journal-title":"Carcinogenesis"},{"key":"BFnsmb3414_CR62","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnsmb3414_CR63","doi-asserted-by":"crossref","unstructured":"Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr 50, 760\u2013763 (1994).","DOI":"10.1107\/S0907444994003112"},{"key":"BFnsmb3414_CR64","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1107\/S0907444903028956","volume":"60","author":"LC Storoni","year":"2004","unstructured":"Storoni, L.C., McCoy, A.J. & Read, R.J. Likelihood-enhanced fast rotation functions. Acta Crystallogr. D Biol. Crystallogr. 60, 432\u2013438 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnsmb3414_CR65","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnsmb3414_CR66","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1107\/S0907444902016657","volume":"58","author":"PD Adams","year":"2002","unstructured":"Adams, P.D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948\u20131954 (2002).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Nature Structural & Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nsmb.3414.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nsmb.3414","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nsmb.3414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nsmb.3414.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:41:40Z","timestamp":1684471300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nsmb.3414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,29]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["BFnsmb3414"],"URL":"https:\/\/doi.org\/10.1038\/nsmb.3414","relation":{},"ISSN":["1545-9993","1545-9985"],"issn-type":[{"value":"1545-9993","type":"print"},{"value":"1545-9985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,29]]},"assertion":[{"value":"3 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}